Access BayerPRO

<p>Stay up to date with exclusive content for Healthcare Professionals:</p><ul><li>Latest updates</li><li>Find useful tools for your practice</li><li>Access patient support materials</li></ul>

Sign up to BayerMED:

Register | Login For Further Access

404 Page

Default

You Are About To Leave The Current Site

Training

Training Title

Learning Materials

Medical Literature 

Chronic Kidney Disease 

Awareness​

Menopause

Clinical Tools 

Contraception

Women's Health

Medical Literature

Prostate Cancer

Heart Failure 

Oncology

Cardio Renal 

Ophthalmology

Bayer Logo

Womens Health.png

Plain Blue Hero Banner.png

Other

small_Cardiovascular_32px.png

Heart Failure

small_Ophthalmology_32px.png

Oncologie

Population-Based Analysis Of The Use Of Radium-223 For Bone-Metastatic Castration-Resistant Prostate Cancer In Ontario, And Of Factors Associated With Treatment Completion And Outcome

media:remote_media:3eafd34c-19e1-4fbc-960b-fee352eae9a3

Population-Based Analysis of Radium-223 for Bone-Metastatic Castration-Resistant Prostate Cancer in Ontario: Treatment Completion and Outcome Factors

Ask a Question